Axa’s Covisint Corporation COVS Stock Holding History

Axa’s Portfolio COVS Stock Details COVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-113,200	Closed	-$1.42M	–	1493
2013 Q4	$1.42M	Buy	+113,200	New	+$1.44M	0.01%	841

Other funds holding COVS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Teton Advisors Rye, New York $142M AUM 42.07% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

ING Group Amsterdam, Netherlands $16.4B AUM 34.6% 1-Year Est. Return

PAM

Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Axa's COVS Position: Q1 2014 in Review

Axa sold out of Covisint Corporation (COVS) in Q1 2014, closing a stake of 113,200 shares — an estimated $1.42M sold.

Axa first reported a position in COVS in Q4 2013 and held it in 1 quarter. The position peaked at $1.42M in Q4 2013. 44 funds tracked by Wall St. Rank hold COVS as of Q1 2014.

Axa reported no remaining Covisint Corporation position as of Q1 2014 after selling out during the quarter.
Axa sold 113,200 Covisint Corporation shares in Q1 2014, an estimated $1.42M.
Axa first reported a position in Covisint Corporation in Q4 2013 and held it in 1 quarter.
Axa's Covisint Corporation position peaked at $1.42M in Q4 2013.
44 funds tracked by Wall St. Rank held Covisint Corporation as of Q1 2014.

Based on Axa's 13F filing for Q1 2014, filed 13 May 2014.